| Name |
Investigation |
Route of administration |
In-vitro / in-vivo |
Imaging / non-imaging |
| Tc99m-pertechnetate |
Thyroid uptake and thyroid imaging
Stomach and salivary gland imaging
Meckel's diverticulum imaging
Brain imaging
Micturating cystogram
First pass blood flow imaging
First pass peripheral vascular imaging |
IV |
In-vivo |
Imaging |
|
| Tc99m-pertechnetate |
Lacrimal imaging |
Eye drops |
In-vivo |
Imaging |
| Tc99m-Human
albumin |
Cardiac blood pool imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Human albumin |
Peripheral vascular imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Human albumin macroaggregates or microspheres |
Lung perfusion imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Human albumin macroaggregates or microspheres |
Lung perfusion imaging with venography |
IV |
In-vivo |
Imaging |
| Tc99m-Phosphonates and phosphates |
Bone imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Phosphonates and phosphates |
Myocardial imaging |
IV |
In-vivo |
Imaging |
| Tc99m-TPA
(diethylenetriaminepenta-acetic acid) |
Renal imaging
First pass blood flow studies
Brain imaging |
IV |
In-vivo |
Imaging |
| Tc99m-TPA
(diethylenetriaminepenta-acetic acid) |
Lung ventilation imaging |
Aerosol inhalation |
In-vivo |
Imaging |
| Tc99m-DMSA(V) (dimercaptosuccinic
acid) |
Tumour imaging |
IV |
In-vivo |
Imaging |
| Tc99m-DMSA(III) (dimercaptosuccinic
acid) |
Renal imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Colloid |
Bone marrow imaging
GI Bleeding |
IV |
In-vivo |
Imaging |
| Tc99m-Colloid |
Lymph node imaging |
Interstitial |
In-vivo |
Imaging |
| Tc99m-Colloid |
Oesophageal transit and reflux imaging |
Oral |
In-vivo |
Imaging |
| Tc99m-Colloid |
Lacrimal imaging |
Eye drops |
In-vivo |
Imaging |
| Tc99m-HIDA (Hepatic iminodiacetic acid) |
Functional biliary system imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Denatured red bood cells |
Red cell volume |
IV |
In-vitro |
Non-imaging |
| Tc99m-Red blood cells |
GI bleeding
Cardiac blood pool imaging
Peripheral vascular imaging |
IV |
In-vivo |
Imaging |
| Tc99m-MAG3 (mercaptoacetyltriglycine) |
Renal imaging
First pass blood flow imaging
|
IV |
In-vivo |
Imaging |
| Tc99m-HMPAO (Hexamethyl-propylene amine oxime) |
Cerebral blood flow imaging |
IV |
In-vivo |
Imaging |
| Tc99m-HMPAO (Hexamethyl-propylene amine oxime) labelled leucocytes |
Infection/inflammation imaging |
IV |
In-vivo |
Imaging |
| Tc99m-estamibi |
Parathyroid imaging
Non-specific tumour imaging
Thyroid tumour imaging
Breast imaging
Myocardial imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Sulesomab (IMMU-MN3 murine Fab'-SH antigranulocyte monoclonal
antibody fragments) |
Infection/inflammation imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Technegas |
Lung ventilation imaging |
Inhalation |
In-vivo |
Imaging |
| Tc99m-Human immunoglobulin |
Infection/inflammation imaging |
IV |
In-vivo |
Imaging |
| Tc99m-Tetrofosmin |
Parathyroid imaging
Myocardial imaging |
IV |
In-vivo |
Imaging |
| Tc99m-ECD (ethyl cysteinate dimer) |
Brain imaging |
IV |
In-vivo |
Imaging |
